首页|血清胃蛋白酶原Ⅰ、胃蛋白酶原Ⅱ、胃泌素17水平在胃癌中的表达及其联合检测对胃癌术后复发的预测价值

血清胃蛋白酶原Ⅰ、胃蛋白酶原Ⅱ、胃泌素17水平在胃癌中的表达及其联合检测对胃癌术后复发的预测价值

扫码查看
目的 探讨血清胃蛋白酶原Ⅰ(PGⅠ)、胃蛋白酶原Ⅰ(PGⅡ)、胃泌素17(G-17)水平在胃癌中的表达及其联合检测对胃癌术后复发的预测价值.方法 选取2017年1月至2022年12月于洛阳市中心医院行根治性手术治疗的116例(均完成1年随访)胃癌患者为观察组,同期116例健康体检者为对照组,另根据术后1年复发情况分为复发(35例)和未复发(81例)两个亚组.比较两组术前血清PGⅠ、PGⅡ、G-17水平,比较不同病理学参数胃癌术前血清PGⅠ、PGⅡ、G-17水平,分析术前血清PGⅠ、PGⅡ、G-17水平与病理学参数相关性,比较复发和未复发胃癌患者血清PGⅠ、PGⅡ、G-17水平,分析血清PGⅠ、PGⅡ、G-17水平联合检测对胃癌术后复发的预测价值.结果 ①与对照组相比,术前观察组血清PGⅠ水平较低,PGⅡ、G-17水平较高(P<0.05).②术前血清PGⅠ水平比较:T1~T2>T3~T4,Ⅰ~Ⅱ期>Ⅲ~Ⅳ期,无淋巴结转移>有淋巴结转移;术前血清PGⅡ、G-17水平比较:T1~T2<T3~T4,Ⅰ~Ⅱ期<Ⅲ~Ⅳ期,无淋巴结转移<有淋巴结转移(P<0.05).③术前血清PGⅠ水平与浸润深度、临床分期、淋巴结转移均呈负相关,血清PGⅡ、G-17水平与浸润深度、临床分期、淋巴结转移均呈正相关(P<0.05).④与未复发患者相比,术后1周、术后4周复发患者血清PGⅠ水平较低,PGⅡ、G-17水平较高(P<0.05).⑤术后1、4周,血清PGⅠ、PGⅡ、G-17联合预测术后复发的AUC均大于各单一指标检测(P<0.05).结论 血清PGⅠ、PGⅡ、G-17与胃癌进展及术后复发显著相关,可作为根治术后复发的预警指标,检测三者表达有望为术后复发的预测提供一种新的策略.
Expression of serum pepsinogen Ⅰ,Pepsinogen Ⅱ and gastrin 17 in gastric cancer and the predictive value of combined detection for postoperative recurrence of gastric cancer
Objective To investigate the expression of serum pepsinogen Ⅰ(PGⅠ),pepsinogen Ⅱ(PGⅡ)and gastrin 17(G-17)in gastric cancer and the predictive value of combined detection for postoperative recurrence of gastric canc-er.Methods A total of 116 patients with gastric cancer who received radical surgery in our hospital from January 2019 to March 2022(all completed 1-year follow-up)were selected as the observation group,and 116 healthy subjects in the same period were selected as the control group.According to the recurrence situation one year after surgery,they were divided into two subgroups:recurrence(35 cases)and non-recurrence(81 cases).The preoperative serum lev-els of PGⅠ,PGⅡ and G-17 were compared between the two groups,the serum levels of PGⅠ,PGⅡ and G-17 were compared before the operation of gastric cancer with different pathological parameters,the correlation between the preop-erative serum levels of PGⅠ,PGⅡ and G-17 and the pathological parameters were analyzed,and the serum levels of PGⅠ,PGⅡ and G-17 were compared between patients with recurrent and non-recurrent gastric cancer.To analyze the combined detection value of serum PGⅠ,PGⅡ and G-17 for postoperative recurrence of gastric cancer.Results ① Compared with the control group,the serum PGⅠ level in the observation group was lower before surgery,while the levels of PGⅡ and G-17 were higher(P<0.05).② Comparison of serum PGⅠ levels before surgery:T1~T2>T3~T4,stages Ⅰ~Ⅱ>Ⅲ~Ⅳ,no lymph node metastasis > with lymph node metastasis;Comparison of ser-um PGⅡ and G-17 levels before surgery:T1~T2<T3~T4,Ⅰ~Ⅱ<Ⅲ~Ⅳ,no lymph node metastasis<with lymph node metastasis(P<0.05).③ Preoperative serum PGⅠ level was negatively correlated with the depth of inva-sion,clinical stage and lymph node metastasis,while serum PGⅡ and G-17 level were positively correlated with the depth of invasion,clinical stage and lymph node metastasis(P<0.05).④ Compared with the patients without recur-rence,the serum PGⅠ level of patients with recurrence 1 week and 4 weeks after surgery was lower,and the serum PGⅡand G-17 levels were higher(P<0.05).⑤ At 1 and 4 weeks after surgery,the AUC of serum PGⅠ,PGⅡ and G-17 combined to predict postoperative recurrence was greater than that of each single index detection(P<0.05).Conclu-sion Serum PGⅠ,PGⅡ,and G-17 are significantly correlated with gastric cancer progression and postoperative recur-rence,and can be used as early warning indicators of recurrence after radical surgery,and the detection of the expres-sion of the three is expected to provide a new strategy for the prediction of postoperative recurrence.

Gastric cancerPostoperative recurrencePGⅠPGⅡG-17

杜世杰

展开 >

洛阳市中心医院检验科,河南洛阳 471000

胃癌 术后复发 血清胃蛋白酶原Ⅰ 胃蛋白酶原Ⅱ 胃泌素17

2024

医药论坛杂志
中华预防医学会,河南省医学情报研究所

医药论坛杂志

影响因子:0.47
ISSN:1672-3422
年,卷(期):2024.45(5)
  • 17